nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—RALBP1—coronary artery disease	0.187	0.552	CbGaD
Doxorubicin—NOS3—coronary artery disease	0.0771	0.228	CbGaD
Doxorubicin—NOS2—coronary artery disease	0.0745	0.22	CbGaD
Doxorubicin—ABCC3—Ezetimibe—coronary artery disease	0.0207	0.0595	CbGbCtD
Doxorubicin—ABCB11—Rosuvastatin—coronary artery disease	0.0179	0.0514	CbGbCtD
Doxorubicin—ABCB11—Pravastatin—coronary artery disease	0.0163	0.0468	CbGbCtD
Doxorubicin—ABCC2—Olmesartan—coronary artery disease	0.016	0.0459	CbGbCtD
Doxorubicin—ABCC2—Telmisartan—coronary artery disease	0.0128	0.0367	CbGbCtD
Doxorubicin—ABCC2—Pitavastatin—coronary artery disease	0.0128	0.0367	CbGbCtD
Doxorubicin—ABCC1—Rosuvastatin—coronary artery disease	0.0127	0.0365	CbGbCtD
Doxorubicin—ABCG2—Pitavastatin—coronary artery disease	0.0115	0.0332	CbGbCtD
Doxorubicin—ABCG2—Telmisartan—coronary artery disease	0.0115	0.0332	CbGbCtD
Doxorubicin—ABCC1—Atorvastatin—coronary artery disease	0.0105	0.0303	CbGbCtD
Doxorubicin—ABCC2—Ezetimibe—coronary artery disease	0.00941	0.027	CbGbCtD
Doxorubicin—CYP2B6—Clopidogrel—coronary artery disease	0.00928	0.0267	CbGbCtD
Doxorubicin—ABCC2—Simvastatin—coronary artery disease	0.00875	0.0251	CbGbCtD
Doxorubicin—ABCC2—Pravastatin—coronary artery disease	0.00856	0.0246	CbGbCtD
Doxorubicin—ABCC2—Lovastatin—coronary artery disease	0.00856	0.0246	CbGbCtD
Doxorubicin—ABCG2—Ezetimibe—coronary artery disease	0.00851	0.0245	CbGbCtD
Doxorubicin—ABCG2—Rosuvastatin—coronary artery disease	0.00851	0.0245	CbGbCtD
Doxorubicin—ABCC2—Atorvastatin—coronary artery disease	0.0078	0.0224	CbGbCtD
Doxorubicin—ABCG2—Pravastatin—coronary artery disease	0.00774	0.0222	CbGbCtD
Doxorubicin—ABCB1—Ticagrelor—coronary artery disease	0.0077	0.0221	CbGbCtD
Doxorubicin—ABCC2—Furosemide—coronary artery disease	0.00728	0.0209	CbGbCtD
Doxorubicin—CYP2B6—Simvastatin—coronary artery disease	0.00556	0.016	CbGbCtD
Doxorubicin—NOS3—femoral artery—coronary artery disease	0.00549	0.0914	CbGeAlD
Doxorubicin—NOS3—thoracic aorta—coronary artery disease	0.0051	0.085	CbGeAlD
Doxorubicin—CYP2B6—Atorvastatin—coronary artery disease	0.00496	0.0143	CbGbCtD
Doxorubicin—ABCB1—Perindopril—coronary artery disease	0.00476	0.0137	CbGbCtD
Doxorubicin—ABCB1—Clopidogrel—coronary artery disease	0.00476	0.0137	CbGbCtD
Doxorubicin—CYP3A4—Ticagrelor—coronary artery disease	0.00462	0.0133	CbGbCtD
Doxorubicin—NOS1—arteriole—coronary artery disease	0.00437	0.0728	CbGeAlD
Doxorubicin—ABCB1—Telmisartan—coronary artery disease	0.00416	0.012	CbGbCtD
Doxorubicin—ABCB1—Pitavastatin—coronary artery disease	0.00416	0.012	CbGbCtD
Doxorubicin—CYP3A4—Fenofibrate—coronary artery disease	0.00411	0.0118	CbGbCtD
Doxorubicin—ABCB1—Enalapril—coronary artery disease	0.00394	0.0113	CbGbCtD
Doxorubicin—ABCB1—Lisinopril—coronary artery disease	0.00394	0.0113	CbGbCtD
Doxorubicin—CYP2D6—Niacin—coronary artery disease	0.0034	0.00977	CbGbCtD
Doxorubicin—ABCB1—Timolol—coronary artery disease	0.00335	0.00964	CbGbCtD
Doxorubicin—NOS3—arteriole—coronary artery disease	0.00333	0.0554	CbGeAlD
Doxorubicin—CYP3A4—Gemfibrozil—coronary artery disease	0.00329	0.00945	CbGbCtD
Doxorubicin—CYP2D6—Timolol—coronary artery disease	0.00316	0.00908	CbGbCtD
Doxorubicin—ABCB1—Ezetimibe—coronary artery disease	0.00307	0.00882	CbGbCtD
Doxorubicin—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00299	0.00859	CbGbCtD
Doxorubicin—ABCB1—Captopril—coronary artery disease	0.00295	0.00849	CbGbCtD
Doxorubicin—CYP3A4—Clopidogrel—coronary artery disease	0.00285	0.0082	CbGbCtD
Doxorubicin—ABCB1—Simvastatin—coronary artery disease	0.00285	0.0082	CbGbCtD
Doxorubicin—ABCB1—Lovastatin—coronary artery disease	0.00279	0.00802	CbGbCtD
Doxorubicin—ABCB1—Pravastatin—coronary artery disease	0.00279	0.00802	CbGbCtD
Doxorubicin—CYP2D6—Captopril—coronary artery disease	0.00278	0.008	CbGbCtD
Doxorubicin—CYP2D6—Simvastatin—coronary artery disease	0.00269	0.00772	CbGbCtD
Doxorubicin—CYP3A4—Eplerenone—coronary artery disease	0.00265	0.00762	CbGbCtD
Doxorubicin—CYP2D6—Pravastatin—coronary artery disease	0.00263	0.00756	CbGbCtD
Doxorubicin—CYP2D6—Lovastatin—coronary artery disease	0.00263	0.00756	CbGbCtD
Doxorubicin—ABCB1—Atorvastatin—coronary artery disease	0.00254	0.00731	CbGbCtD
Doxorubicin—CYP2D6—Atorvastatin—coronary artery disease	0.00239	0.00688	CbGbCtD
Doxorubicin—CYP3A4—Enalapril—coronary artery disease	0.00236	0.00679	CbGbCtD
Doxorubicin—NOS3—tunica intima—coronary artery disease	0.00236	0.0393	CbGeAlD
Doxorubicin—ABCB1—Losartan—coronary artery disease	0.00232	0.00668	CbGbCtD
Doxorubicin—NOS3—pulmonary artery—coronary artery disease	0.00218	0.0363	CbGeAlD
Doxorubicin—NOS3—vein—coronary artery disease	0.00198	0.033	CbGeAlD
Doxorubicin—CYP3A4—Ezetimibe—coronary artery disease	0.00184	0.00528	CbGbCtD
Doxorubicin—CYP3A4—Rosuvastatin—coronary artery disease	0.00184	0.00528	CbGbCtD
Doxorubicin—CYP3A4—Simvastatin—coronary artery disease	0.00171	0.00491	CbGbCtD
Doxorubicin—CYP3A4—Lovastatin—coronary artery disease	0.00167	0.00481	CbGbCtD
Doxorubicin—CYP3A4—Pravastatin—coronary artery disease	0.00167	0.00481	CbGbCtD
Doxorubicin—CYP3A4—Atorvastatin—coronary artery disease	0.00152	0.00438	CbGbCtD
Doxorubicin—CYP3A4—Losartan—coronary artery disease	0.00139	0.004	CbGbCtD
Doxorubicin—NOS1—artery—coronary artery disease	0.00106	0.0177	CbGeAlD
Doxorubicin—NOS1—endothelium—coronary artery disease	0.000897	0.0149	CbGeAlD
Doxorubicin—NOS3—artery—coronary artery disease	0.000808	0.0135	CbGeAlD
Doxorubicin—AKR1A1—cardiac ventricle—coronary artery disease	0.000786	0.0131	CbGeAlD
Doxorubicin—AKR1A1—myocardium—coronary artery disease	0.00074	0.0123	CbGeAlD
Doxorubicin—NDUFS7—cardiac ventricle—coronary artery disease	0.000715	0.0119	CbGeAlD
Doxorubicin—ABCB8—heart—coronary artery disease	0.000695	0.0116	CbGeAlD
Doxorubicin—NOS3—endothelium—coronary artery disease	0.000682	0.0114	CbGeAlD
Doxorubicin—NDUFS7—myocardium—coronary artery disease	0.000672	0.0112	CbGeAlD
Doxorubicin—CBR3—heart—coronary artery disease	0.000669	0.0111	CbGeAlD
Doxorubicin—SLC22A16—blood—coronary artery disease	0.000666	0.0111	CbGeAlD
Doxorubicin—AURKA—myocardium—coronary artery disease	0.000625	0.0104	CbGeAlD
Doxorubicin—NDUFS2—cardiac ventricle—coronary artery disease	0.000592	0.00986	CbGeAlD
Doxorubicin—CBR3—Nitazoxanide—Acetylsalicylic acid—coronary artery disease	0.000587	0.262	CbGdCrCtD
Doxorubicin—NDUFS3—cardiac ventricle—coronary artery disease	0.000585	0.00974	CbGeAlD
Doxorubicin—NDUFS2—myocardium—coronary artery disease	0.000557	0.00928	CbGeAlD
Doxorubicin—NDUFS3—myocardium—coronary artery disease	0.00055	0.00916	CbGeAlD
Doxorubicin—ABCB8—blood—coronary artery disease	0.000518	0.00863	CbGeAlD
Doxorubicin—AKR1A1—heart—coronary artery disease	0.000516	0.0086	CbGeAlD
Doxorubicin—YWHAG—cardiac ventricle—coronary artery disease	0.00051	0.00849	CbGeAlD
Doxorubicin—CBR3—blood—coronary artery disease	0.000499	0.00831	CbGeAlD
Doxorubicin—AKR1A1—cardiovascular system—coronary artery disease	0.000487	0.00811	CbGeAlD
Doxorubicin—YWHAG—myocardium—coronary artery disease	0.00048	0.00799	CbGeAlD
Doxorubicin—NDUFS7—heart—coronary artery disease	0.000469	0.00781	CbGeAlD
Doxorubicin—RALBP1—cardiac ventricle—coronary artery disease	0.00046	0.00767	CbGeAlD
Doxorubicin—NOS3—cardiac ventricle—coronary artery disease	0.000453	0.00755	CbGeAlD
Doxorubicin—NDUFS7—cardiovascular system—coronary artery disease	0.000443	0.00737	CbGeAlD
Doxorubicin—AKR1A1—cardiac atrium—coronary artery disease	0.000442	0.00735	CbGeAlD
Doxorubicin—AURKA—heart—coronary artery disease	0.000436	0.00726	CbGeAlD
Doxorubicin—RALBP1—myocardium—coronary artery disease	0.000433	0.00721	CbGeAlD
Doxorubicin—NOS3—myocardium—coronary artery disease	0.000426	0.0071	CbGeAlD
Doxorubicin—AKR1C3—cardiac ventricle—coronary artery disease	0.000425	0.00707	CbGeAlD
Doxorubicin—CBR1—myocardium—coronary artery disease	0.000404	0.00673	CbGeAlD
Doxorubicin—NDUFS7—cardiac atrium—coronary artery disease	0.000401	0.00668	CbGeAlD
Doxorubicin—AKR1C3—myocardium—coronary artery disease	0.000399	0.00665	CbGeAlD
Doxorubicin—NOS1—heart—coronary artery disease	0.000391	0.00652	CbGeAlD
Doxorubicin—NDUFS2—heart—coronary artery disease	0.000389	0.00647	CbGeAlD
Doxorubicin—AKR1A1—blood—coronary artery disease	0.000385	0.00642	CbGeAlD
Doxorubicin—NDUFS3—heart—coronary artery disease	0.000384	0.0064	CbGeAlD
Doxorubicin—NOS1—cardiovascular system—coronary artery disease	0.000369	0.00615	CbGeAlD
Doxorubicin—NDUFS2—cardiovascular system—coronary artery disease	0.000367	0.00611	CbGeAlD
Doxorubicin—DHCR7—heart—coronary artery disease	0.000365	0.00608	CbGeAlD
Doxorubicin—POR—myocardium—coronary artery disease	0.000365	0.00607	CbGeAlD
Doxorubicin—NDUFS3—cardiovascular system—coronary artery disease	0.000362	0.00603	CbGeAlD
Doxorubicin—NDUFS7—blood—coronary artery disease	0.00035	0.00583	CbGeAlD
Doxorubicin—ABCC6—cardiovascular system—coronary artery disease	0.000336	0.00559	CbGeAlD
Doxorubicin—YWHAG—heart—coronary artery disease	0.000335	0.00558	CbGeAlD
Doxorubicin—NDUFS2—cardiac atrium—coronary artery disease	0.000333	0.00554	CbGeAlD
Doxorubicin—NDUFS3—cardiac atrium—coronary artery disease	0.000328	0.00547	CbGeAlD
Doxorubicin—AURKA—blood—coronary artery disease	0.000325	0.00542	CbGeAlD
Doxorubicin—YWHAG—cardiovascular system—coronary artery disease	0.000316	0.00526	CbGeAlD
Doxorubicin—DHCR7—cardiac atrium—coronary artery disease	0.000312	0.0052	CbGeAlD
Doxorubicin—ABCC10—cardiac ventricle—coronary artery disease	0.000308	0.00512	CbGeAlD
Doxorubicin—RALBP1—heart—coronary artery disease	0.000302	0.00504	CbGeAlD
Doxorubicin—NOS3—heart—coronary artery disease	0.000297	0.00495	CbGeAlD
Doxorubicin—NOS1—blood—coronary artery disease	0.000292	0.00486	CbGeAlD
Doxorubicin—NDUFS2—blood—coronary artery disease	0.00029	0.00483	CbGeAlD
Doxorubicin—NDUFS3—blood—coronary artery disease	0.000287	0.00477	CbGeAlD
Doxorubicin—YWHAG—cardiac atrium—coronary artery disease	0.000286	0.00477	CbGeAlD
Doxorubicin—RALBP1—cardiovascular system—coronary artery disease	0.000285	0.00475	CbGeAlD
Doxorubicin—CBR1—heart—coronary artery disease	0.000282	0.0047	CbGeAlD
Doxorubicin—NOS3—cardiovascular system—coronary artery disease	0.000281	0.00467	CbGeAlD
Doxorubicin—AKR1C3—heart—coronary artery disease	0.000279	0.00464	CbGeAlD
Doxorubicin—DHCR7—blood—coronary artery disease	0.000272	0.00453	CbGeAlD
Doxorubicin—CBR1—cardiovascular system—coronary artery disease	0.000266	0.00444	CbGeAlD
Doxorubicin—ABCC6—blood—coronary artery disease	0.000265	0.00442	CbGeAlD
Doxorubicin—AURKA—Fluvastatin—Pitavastatin—coronary artery disease	0.000262	0.117	CbGdCrCtD
Doxorubicin—RALBP1—cardiac atrium—coronary artery disease	0.000259	0.00431	CbGeAlD
Doxorubicin—POR—heart—coronary artery disease	0.000255	0.00424	CbGeAlD
Doxorubicin—YWHAG—blood—coronary artery disease	0.00025	0.00416	CbGeAlD
Doxorubicin—CBR1—cardiac atrium—coronary artery disease	0.000241	0.00402	CbGeAlD
Doxorubicin—AKR1C3—cardiac atrium—coronary artery disease	0.000238	0.00397	CbGeAlD
Doxorubicin—AURKA—Fluvastatin—Rosuvastatin—coronary artery disease	0.000233	0.104	CbGdCrCtD
Doxorubicin—NQO1—heart—coronary artery disease	0.000226	0.00377	CbGeAlD
Doxorubicin—RALBP1—blood—coronary artery disease	0.000226	0.00376	CbGeAlD
Doxorubicin—AURKA—Simvastatin—Pravastatin—coronary artery disease	0.000223	0.0994	CbGdCrCtD
Doxorubicin—AURKA—Simvastatin—Lovastatin—coronary artery disease	0.000223	0.0994	CbGdCrCtD
Doxorubicin—NOS3—blood—coronary artery disease	0.000222	0.0037	CbGeAlD
Doxorubicin—POR—cardiac atrium—coronary artery disease	0.000218	0.00363	CbGeAlD
Doxorubicin—NQO1—cardiovascular system—coronary artery disease	0.000213	0.00355	CbGeAlD
Doxorubicin—CBR1—blood—coronary artery disease	0.000211	0.00351	CbGeAlD
Doxorubicin—AKR1C3—blood—coronary artery disease	0.000208	0.00346	CbGeAlD
Doxorubicin—ABCC1—myocardium—coronary artery disease	0.000205	0.00341	CbGeAlD
Doxorubicin—ABCC10—heart—coronary artery disease	0.000202	0.00336	CbGeAlD
Doxorubicin—AURKA—Fluvastatin—Atorvastatin—coronary artery disease	0.000198	0.0884	CbGdCrCtD
Doxorubicin—POR—blood—coronary artery disease	0.00019	0.00316	CbGeAlD
Doxorubicin—TOP2A—blood—coronary artery disease	0.000177	0.00295	CbGeAlD
Doxorubicin—ABCC10—cardiac atrium—coronary artery disease	0.000173	0.00288	CbGeAlD
Doxorubicin—CYP1B1—heart—coronary artery disease	0.000159	0.00265	CbGeAlD
Doxorubicin—ABCC3—blood—coronary artery disease	0.000151	0.00252	CbGeAlD
Doxorubicin—ABCC10—blood—coronary artery disease	0.000151	0.00251	CbGeAlD
Doxorubicin—CYP1B1—cardiovascular system—coronary artery disease	0.00015	0.0025	CbGeAlD
Doxorubicin—ABCC1—heart—coronary artery disease	0.000143	0.00238	CbGeAlD
Doxorubicin—ABCC1—cardiac atrium—coronary artery disease	0.000122	0.00203	CbGeAlD
Doxorubicin—ABCC2—blood—coronary artery disease	0.000121	0.00202	CbGeAlD
Doxorubicin—CYP1B1—blood—coronary artery disease	0.000119	0.00197	CbGeAlD
Doxorubicin—ABCG2—heart—coronary artery disease	0.000118	0.00197	CbGeAlD
Doxorubicin—CYP2B6—heart—coronary artery disease	0.000109	0.00182	CbGeAlD
Doxorubicin—ABCC1—blood—coronary artery disease	0.000107	0.00178	CbGeAlD
Doxorubicin—CYP2B6—cardiovascular system—coronary artery disease	0.000103	0.00171	CbGeAlD
Doxorubicin—TOP2A—Fluvastatin—Pitavastatin—coronary artery disease	0.0001	0.0445	CbGdCrCtD
Doxorubicin—TOP2A—Fluvastatin—Rosuvastatin—coronary artery disease	8.91e-05	0.0397	CbGdCrCtD
Doxorubicin—ABCG2—blood—coronary artery disease	8.83e-05	0.00147	CbGeAlD
Doxorubicin—TOP2A—Simvastatin—Pravastatin—coronary artery disease	8.52e-05	0.038	CbGdCrCtD
Doxorubicin—TOP2A—Simvastatin—Lovastatin—coronary artery disease	8.52e-05	0.038	CbGdCrCtD
Doxorubicin—CYP2B6—blood—coronary artery disease	8.14e-05	0.00136	CbGeAlD
Doxorubicin—TOP2A—Fluvastatin—Atorvastatin—coronary artery disease	7.57e-05	0.0338	CbGdCrCtD
Doxorubicin—CYP3A4—blood—coronary artery disease	6.15e-05	0.00102	CbGeAlD
Doxorubicin—CYP2D6—blood—coronary artery disease	6.05e-05	0.00101	CbGeAlD
Doxorubicin—ABCB1—heart—coronary artery disease	5.83e-05	0.000971	CbGeAlD
Doxorubicin—ABCB1—cardiovascular system—coronary artery disease	5.5e-05	0.000916	CbGeAlD
Doxorubicin—TOP2A—Alprenolol—Penbutolol—coronary artery disease	4.88e-05	0.0217	CbGdCrCtD
Doxorubicin—ABCB1—blood—coronary artery disease	4.35e-05	0.000725	CbGeAlD
Doxorubicin—TOP2A—Methyltestosterone—Eplerenone—coronary artery disease	3.39e-05	0.0151	CbGdCrCtD
Doxorubicin—Malaise—Lisinopril—coronary artery disease	2.07e-05	0.000148	CcSEcCtD
Doxorubicin—Anaphylactic shock—Ramipril—coronary artery disease	2.06e-05	0.000148	CcSEcCtD
Doxorubicin—Oedema—Ramipril—coronary artery disease	2.06e-05	0.000148	CcSEcCtD
Doxorubicin—Vertigo—Lisinopril—coronary artery disease	2.06e-05	0.000148	CcSEcCtD
Doxorubicin—Dry mouth—Timolol—coronary artery disease	2.06e-05	0.000148	CcSEcCtD
Doxorubicin—Pain—Losartan—coronary artery disease	2.06e-05	0.000148	CcSEcCtD
Doxorubicin—Constipation—Losartan—coronary artery disease	2.06e-05	0.000148	CcSEcCtD
Doxorubicin—Syncope—Lisinopril—coronary artery disease	2.06e-05	0.000147	CcSEcCtD
Doxorubicin—Vomiting—Eplerenone—coronary artery disease	2.06e-05	0.000147	CcSEcCtD
Doxorubicin—Feeling abnormal—Furosemide—coronary artery disease	2.06e-05	0.000147	CcSEcCtD
Doxorubicin—Leukopenia—Lisinopril—coronary artery disease	2.05e-05	0.000147	CcSEcCtD
Doxorubicin—Nausea—Fenofibrate—coronary artery disease	2.05e-05	0.000147	CcSEcCtD
Doxorubicin—Pruritus—Niacin—coronary artery disease	2.05e-05	0.000147	CcSEcCtD
Doxorubicin—Asthenia—Pravastatin—coronary artery disease	2.04e-05	0.000147	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Furosemide—coronary artery disease	2.04e-05	0.000146	CcSEcCtD
Doxorubicin—Rash—Eplerenone—coronary artery disease	2.04e-05	0.000146	CcSEcCtD
Doxorubicin—Urticaria—Perindopril—coronary artery disease	2.04e-05	0.000146	CcSEcCtD
Doxorubicin—Hypersensitivity—Trandolapril—coronary artery disease	2.04e-05	0.000146	CcSEcCtD
Doxorubicin—Dermatitis—Eplerenone—coronary artery disease	2.04e-05	0.000146	CcSEcCtD
Doxorubicin—Diarrhoea—Valsartan—coronary artery disease	2.04e-05	0.000146	CcSEcCtD
Doxorubicin—Confusional state—Timolol—coronary artery disease	2.03e-05	0.000146	CcSEcCtD
Doxorubicin—Shock—Ramipril—coronary artery disease	2.03e-05	0.000146	CcSEcCtD
Doxorubicin—Hypersensitivity—Enalapril—coronary artery disease	2.03e-05	0.000146	CcSEcCtD
Doxorubicin—Abdominal pain—Perindopril—coronary artery disease	2.03e-05	0.000145	CcSEcCtD
Doxorubicin—Body temperature increased—Perindopril—coronary artery disease	2.03e-05	0.000145	CcSEcCtD
Doxorubicin—Palpitations—Lisinopril—coronary artery disease	2.03e-05	0.000145	CcSEcCtD
Doxorubicin—Diarrhoea—Olmesartan—coronary artery disease	2.03e-05	0.000145	CcSEcCtD
Doxorubicin—Headache—Eplerenone—coronary artery disease	2.03e-05	0.000145	CcSEcCtD
Doxorubicin—Nervous system disorder—Ramipril—coronary artery disease	2.02e-05	0.000145	CcSEcCtD
Doxorubicin—Thrombocytopenia—Ramipril—coronary artery disease	2.02e-05	0.000145	CcSEcCtD
Doxorubicin—Oedema—Timolol—coronary artery disease	2.02e-05	0.000145	CcSEcCtD
Doxorubicin—Anaphylactic shock—Timolol—coronary artery disease	2.02e-05	0.000145	CcSEcCtD
Doxorubicin—Pruritus—Pravastatin—coronary artery disease	2.02e-05	0.000145	CcSEcCtD
Doxorubicin—Loss of consciousness—Lisinopril—coronary artery disease	2.02e-05	0.000145	CcSEcCtD
Doxorubicin—Nausea—Clopidogrel—coronary artery disease	2.01e-05	0.000144	CcSEcCtD
Doxorubicin—Tachycardia—Ramipril—coronary artery disease	2.01e-05	0.000144	CcSEcCtD
Doxorubicin—Skin disorder—Ramipril—coronary artery disease	2e-05	0.000144	CcSEcCtD
Doxorubicin—Infection—Timolol—coronary artery disease	2e-05	0.000144	CcSEcCtD
Doxorubicin—Vomiting—Simvastatin—coronary artery disease	2e-05	0.000144	CcSEcCtD
Doxorubicin—Hypersensitivity—Telmisartan—coronary artery disease	2e-05	0.000144	CcSEcCtD
Doxorubicin—Cough—Lisinopril—coronary artery disease	2e-05	0.000143	CcSEcCtD
Doxorubicin—Nausea—Lovastatin—coronary artery disease	2e-05	0.000143	CcSEcCtD
Doxorubicin—Hyperhidrosis—Ramipril—coronary artery disease	2e-05	0.000143	CcSEcCtD
Doxorubicin—Rash—Simvastatin—coronary artery disease	1.99e-05	0.000142	CcSEcCtD
Doxorubicin—Dermatitis—Simvastatin—coronary artery disease	1.99e-05	0.000142	CcSEcCtD
Doxorubicin—Asthenia—Trandolapril—coronary artery disease	1.99e-05	0.000142	CcSEcCtD
Doxorubicin—Shock—Timolol—coronary artery disease	1.99e-05	0.000142	CcSEcCtD
Doxorubicin—Feeling abnormal—Losartan—coronary artery disease	1.98e-05	0.000142	CcSEcCtD
Doxorubicin—Urticaria—Furosemide—coronary artery disease	1.98e-05	0.000142	CcSEcCtD
Doxorubicin—Diarrhoea—Niacin—coronary artery disease	1.98e-05	0.000142	CcSEcCtD
Doxorubicin—Nervous system disorder—Timolol—coronary artery disease	1.98e-05	0.000142	CcSEcCtD
Doxorubicin—Asthenia—Enalapril—coronary artery disease	1.98e-05	0.000142	CcSEcCtD
Doxorubicin—Headache—Simvastatin—coronary artery disease	1.97e-05	0.000142	CcSEcCtD
Doxorubicin—Abdominal pain—Furosemide—coronary artery disease	1.97e-05	0.000141	CcSEcCtD
Doxorubicin—Body temperature increased—Furosemide—coronary artery disease	1.97e-05	0.000141	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Losartan—coronary artery disease	1.97e-05	0.000141	CcSEcCtD
Doxorubicin—Dizziness—Valsartan—coronary artery disease	1.97e-05	0.000141	CcSEcCtD
Doxorubicin—Anorexia—Ramipril—coronary artery disease	1.97e-05	0.000141	CcSEcCtD
Doxorubicin—Nausea—Ezetimibe—coronary artery disease	1.96e-05	0.000141	CcSEcCtD
Doxorubicin—Skin disorder—Timolol—coronary artery disease	1.96e-05	0.000141	CcSEcCtD
Doxorubicin—Dizziness—Olmesartan—coronary artery disease	1.96e-05	0.00014	CcSEcCtD
Doxorubicin—Pruritus—Trandolapril—coronary artery disease	1.96e-05	0.00014	CcSEcCtD
Doxorubicin—Chest pain—Lisinopril—coronary artery disease	1.95e-05	0.00014	CcSEcCtD
Doxorubicin—Myalgia—Lisinopril—coronary artery disease	1.95e-05	0.00014	CcSEcCtD
Doxorubicin—Arthralgia—Lisinopril—coronary artery disease	1.95e-05	0.00014	CcSEcCtD
Doxorubicin—Hyperhidrosis—Timolol—coronary artery disease	1.95e-05	0.00014	CcSEcCtD
Doxorubicin—Asthenia—Telmisartan—coronary artery disease	1.95e-05	0.00014	CcSEcCtD
Doxorubicin—Pruritus—Enalapril—coronary artery disease	1.95e-05	0.00014	CcSEcCtD
Doxorubicin—Diarrhoea—Pravastatin—coronary artery disease	1.95e-05	0.00014	CcSEcCtD
Doxorubicin—Anxiety—Lisinopril—coronary artery disease	1.95e-05	0.000139	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	1.94e-05	0.000139	CcSEcCtD
Doxorubicin—Discomfort—Lisinopril—coronary artery disease	1.93e-05	0.000138	CcSEcCtD
Doxorubicin—Hypotension—Ramipril—coronary artery disease	1.93e-05	0.000138	CcSEcCtD
Doxorubicin—Anorexia—Timolol—coronary artery disease	1.92e-05	0.000138	CcSEcCtD
Doxorubicin—Pruritus—Telmisartan—coronary artery disease	1.92e-05	0.000138	CcSEcCtD
Doxorubicin—Nausea—Eplerenone—coronary artery disease	1.92e-05	0.000138	CcSEcCtD
Doxorubicin—Dizziness—Niacin—coronary artery disease	1.91e-05	0.000137	CcSEcCtD
Doxorubicin—Urticaria—Losartan—coronary artery disease	1.91e-05	0.000137	CcSEcCtD
Doxorubicin—Dry mouth—Lisinopril—coronary artery disease	1.91e-05	0.000137	CcSEcCtD
Doxorubicin—Abdominal pain—Losartan—coronary artery disease	1.9e-05	0.000136	CcSEcCtD
Doxorubicin—Body temperature increased—Losartan—coronary artery disease	1.9e-05	0.000136	CcSEcCtD
Doxorubicin—Asthenia—Captopril—coronary artery disease	1.9e-05	0.000136	CcSEcCtD
Doxorubicin—Diarrhoea—Trandolapril—coronary artery disease	1.89e-05	0.000136	CcSEcCtD
Doxorubicin—Vomiting—Valsartan—coronary artery disease	1.89e-05	0.000136	CcSEcCtD
Doxorubicin—Confusional state—Lisinopril—coronary artery disease	1.89e-05	0.000135	CcSEcCtD
Doxorubicin—Diarrhoea—Enalapril—coronary artery disease	1.89e-05	0.000135	CcSEcCtD
Doxorubicin—Hypotension—Timolol—coronary artery disease	1.89e-05	0.000135	CcSEcCtD
Doxorubicin—Dizziness—Pravastatin—coronary artery disease	1.88e-05	0.000135	CcSEcCtD
Doxorubicin—Vomiting—Olmesartan—coronary artery disease	1.88e-05	0.000135	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Ramipril—coronary artery disease	1.88e-05	0.000135	CcSEcCtD
Doxorubicin—Rash—Valsartan—coronary artery disease	1.88e-05	0.000135	CcSEcCtD
Doxorubicin—Dermatitis—Valsartan—coronary artery disease	1.87e-05	0.000134	CcSEcCtD
Doxorubicin—Nausea—Simvastatin—coronary artery disease	1.87e-05	0.000134	CcSEcCtD
Doxorubicin—Anaphylactic shock—Lisinopril—coronary artery disease	1.87e-05	0.000134	CcSEcCtD
Doxorubicin—Oedema—Lisinopril—coronary artery disease	1.87e-05	0.000134	CcSEcCtD
Doxorubicin—Pruritus—Captopril—coronary artery disease	1.87e-05	0.000134	CcSEcCtD
Doxorubicin—Rash—Olmesartan—coronary artery disease	1.87e-05	0.000134	CcSEcCtD
Doxorubicin—Insomnia—Ramipril—coronary artery disease	1.87e-05	0.000134	CcSEcCtD
Doxorubicin—Dermatitis—Olmesartan—coronary artery disease	1.87e-05	0.000134	CcSEcCtD
Doxorubicin—Headache—Valsartan—coronary artery disease	1.86e-05	0.000134	CcSEcCtD
Doxorubicin—Diarrhoea—Telmisartan—coronary artery disease	1.86e-05	0.000133	CcSEcCtD
Doxorubicin—Infection—Lisinopril—coronary artery disease	1.86e-05	0.000133	CcSEcCtD
Doxorubicin—Headache—Olmesartan—coronary artery disease	1.86e-05	0.000133	CcSEcCtD
Doxorubicin—Paraesthesia—Ramipril—coronary artery disease	1.85e-05	0.000133	CcSEcCtD
Doxorubicin—Shock—Lisinopril—coronary artery disease	1.84e-05	0.000132	CcSEcCtD
Doxorubicin—Asthenia—Perindopril—coronary artery disease	1.84e-05	0.000132	CcSEcCtD
Doxorubicin—Dyspnoea—Ramipril—coronary artery disease	1.84e-05	0.000132	CcSEcCtD
Doxorubicin—Vomiting—Niacin—coronary artery disease	1.84e-05	0.000132	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Timolol—coronary artery disease	1.84e-05	0.000132	CcSEcCtD
Doxorubicin—Hypersensitivity—Furosemide—coronary artery disease	1.84e-05	0.000132	CcSEcCtD
Doxorubicin—Somnolence—Ramipril—coronary artery disease	1.83e-05	0.000132	CcSEcCtD
Doxorubicin—Thrombocytopenia—Lisinopril—coronary artery disease	1.83e-05	0.000131	CcSEcCtD
Doxorubicin—Dizziness—Trandolapril—coronary artery disease	1.83e-05	0.000131	CcSEcCtD
Doxorubicin—Tachycardia—Lisinopril—coronary artery disease	1.83e-05	0.000131	CcSEcCtD
Doxorubicin—Insomnia—Timolol—coronary artery disease	1.82e-05	0.000131	CcSEcCtD
Doxorubicin—Rash—Niacin—coronary artery disease	1.82e-05	0.000131	CcSEcCtD
Doxorubicin—Dermatitis—Niacin—coronary artery disease	1.82e-05	0.000131	CcSEcCtD
Doxorubicin—Dizziness—Enalapril—coronary artery disease	1.82e-05	0.000131	CcSEcCtD
Doxorubicin—Skin disorder—Lisinopril—coronary artery disease	1.82e-05	0.00013	CcSEcCtD
Doxorubicin—Dyspepsia—Ramipril—coronary artery disease	1.82e-05	0.00013	CcSEcCtD
Doxorubicin—Pruritus—Perindopril—coronary artery disease	1.82e-05	0.00013	CcSEcCtD
Doxorubicin—Headache—Niacin—coronary artery disease	1.81e-05	0.00013	CcSEcCtD
Doxorubicin—Paraesthesia—Timolol—coronary artery disease	1.81e-05	0.00013	CcSEcCtD
Doxorubicin—Vomiting—Pravastatin—coronary artery disease	1.81e-05	0.00013	CcSEcCtD
Doxorubicin—Hyperhidrosis—Lisinopril—coronary artery disease	1.81e-05	0.00013	CcSEcCtD
Doxorubicin—Diarrhoea—Captopril—coronary artery disease	1.81e-05	0.00013	CcSEcCtD
Doxorubicin—Dyspnoea—Timolol—coronary artery disease	1.8e-05	0.000129	CcSEcCtD
Doxorubicin—Dizziness—Telmisartan—coronary artery disease	1.8e-05	0.000129	CcSEcCtD
Doxorubicin—Rash—Pravastatin—coronary artery disease	1.8e-05	0.000129	CcSEcCtD
Doxorubicin—Dermatitis—Pravastatin—coronary artery disease	1.79e-05	0.000129	CcSEcCtD
Doxorubicin—Decreased appetite—Ramipril—coronary artery disease	1.79e-05	0.000129	CcSEcCtD
Doxorubicin—Somnolence—Timolol—coronary artery disease	1.79e-05	0.000129	CcSEcCtD
Doxorubicin—Asthenia—Furosemide—coronary artery disease	1.79e-05	0.000128	CcSEcCtD
Doxorubicin—Headache—Pravastatin—coronary artery disease	1.78e-05	0.000128	CcSEcCtD
Doxorubicin—Anorexia—Lisinopril—coronary artery disease	1.78e-05	0.000128	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Ramipril—coronary artery disease	1.78e-05	0.000128	CcSEcCtD
Doxorubicin—Fatigue—Ramipril—coronary artery disease	1.78e-05	0.000128	CcSEcCtD
Doxorubicin—Dyspepsia—Timolol—coronary artery disease	1.78e-05	0.000127	CcSEcCtD
Doxorubicin—Hypersensitivity—Losartan—coronary artery disease	1.77e-05	0.000127	CcSEcCtD
Doxorubicin—Nausea—Valsartan—coronary artery disease	1.77e-05	0.000127	CcSEcCtD
Doxorubicin—Pruritus—Furosemide—coronary artery disease	1.77e-05	0.000127	CcSEcCtD
Doxorubicin—Constipation—Ramipril—coronary artery disease	1.76e-05	0.000127	CcSEcCtD
Doxorubicin—Nausea—Olmesartan—coronary artery disease	1.76e-05	0.000126	CcSEcCtD
Doxorubicin—Vomiting—Trandolapril—coronary artery disease	1.76e-05	0.000126	CcSEcCtD
Doxorubicin—Diarrhoea—Perindopril—coronary artery disease	1.76e-05	0.000126	CcSEcCtD
Doxorubicin—Decreased appetite—Timolol—coronary artery disease	1.75e-05	0.000126	CcSEcCtD
Doxorubicin—Vomiting—Enalapril—coronary artery disease	1.75e-05	0.000126	CcSEcCtD
Doxorubicin—Hypotension—Lisinopril—coronary artery disease	1.75e-05	0.000125	CcSEcCtD
Doxorubicin—Dizziness—Captopril—coronary artery disease	1.75e-05	0.000125	CcSEcCtD
Doxorubicin—Rash—Trandolapril—coronary artery disease	1.74e-05	0.000125	CcSEcCtD
Doxorubicin—Dermatitis—Trandolapril—coronary artery disease	1.74e-05	0.000125	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Timolol—coronary artery disease	1.74e-05	0.000125	CcSEcCtD
Doxorubicin—Fatigue—Timolol—coronary artery disease	1.74e-05	0.000125	CcSEcCtD
Doxorubicin—Rash—Enalapril—coronary artery disease	1.74e-05	0.000125	CcSEcCtD
Doxorubicin—Dermatitis—Enalapril—coronary artery disease	1.74e-05	0.000124	CcSEcCtD
Doxorubicin—Headache—Trandolapril—coronary artery disease	1.73e-05	0.000124	CcSEcCtD
Doxorubicin—Vomiting—Telmisartan—coronary artery disease	1.73e-05	0.000124	CcSEcCtD
Doxorubicin—Asthenia—Losartan—coronary artery disease	1.73e-05	0.000124	CcSEcCtD
Doxorubicin—Headache—Enalapril—coronary artery disease	1.73e-05	0.000124	CcSEcCtD
Doxorubicin—Pain—Timolol—coronary artery disease	1.73e-05	0.000124	CcSEcCtD
Doxorubicin—Nausea—Niacin—coronary artery disease	1.72e-05	0.000123	CcSEcCtD
Doxorubicin—Rash—Telmisartan—coronary artery disease	1.71e-05	0.000123	CcSEcCtD
Doxorubicin—Dermatitis—Telmisartan—coronary artery disease	1.71e-05	0.000123	CcSEcCtD
Doxorubicin—Diarrhoea—Furosemide—coronary artery disease	1.71e-05	0.000122	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Lisinopril—coronary artery disease	1.71e-05	0.000122	CcSEcCtD
Doxorubicin—Pruritus—Losartan—coronary artery disease	1.7e-05	0.000122	CcSEcCtD
Doxorubicin—Headache—Telmisartan—coronary artery disease	1.7e-05	0.000122	CcSEcCtD
Doxorubicin—Feeling abnormal—Ramipril—coronary artery disease	1.7e-05	0.000122	CcSEcCtD
Doxorubicin—Dizziness—Perindopril—coronary artery disease	1.7e-05	0.000122	CcSEcCtD
Doxorubicin—Insomnia—Lisinopril—coronary artery disease	1.69e-05	0.000121	CcSEcCtD
Doxorubicin—Nausea—Pravastatin—coronary artery disease	1.69e-05	0.000121	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Ramipril—coronary artery disease	1.69e-05	0.000121	CcSEcCtD
Doxorubicin—Paraesthesia—Lisinopril—coronary artery disease	1.68e-05	0.00012	CcSEcCtD
Doxorubicin—Vomiting—Captopril—coronary artery disease	1.68e-05	0.00012	CcSEcCtD
Doxorubicin—Dyspnoea—Lisinopril—coronary artery disease	1.67e-05	0.00012	CcSEcCtD
Doxorubicin—Rash—Captopril—coronary artery disease	1.67e-05	0.000119	CcSEcCtD
Doxorubicin—Dermatitis—Captopril—coronary artery disease	1.67e-05	0.000119	CcSEcCtD
Doxorubicin—Somnolence—Lisinopril—coronary artery disease	1.66e-05	0.000119	CcSEcCtD
Doxorubicin—Feeling abnormal—Timolol—coronary artery disease	1.66e-05	0.000119	CcSEcCtD
Doxorubicin—Headache—Captopril—coronary artery disease	1.66e-05	0.000119	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Timolol—coronary artery disease	1.65e-05	0.000118	CcSEcCtD
Doxorubicin—Dizziness—Furosemide—coronary artery disease	1.65e-05	0.000118	CcSEcCtD
Doxorubicin—Dyspepsia—Lisinopril—coronary artery disease	1.65e-05	0.000118	CcSEcCtD
Doxorubicin—Diarrhoea—Losartan—coronary artery disease	1.65e-05	0.000118	CcSEcCtD
Doxorubicin—Nausea—Trandolapril—coronary artery disease	1.64e-05	0.000118	CcSEcCtD
Doxorubicin—Urticaria—Ramipril—coronary artery disease	1.64e-05	0.000118	CcSEcCtD
Doxorubicin—Nausea—Enalapril—coronary artery disease	1.64e-05	0.000117	CcSEcCtD
Doxorubicin—Vomiting—Perindopril—coronary artery disease	1.63e-05	0.000117	CcSEcCtD
Doxorubicin—Abdominal pain—Ramipril—coronary artery disease	1.63e-05	0.000117	CcSEcCtD
Doxorubicin—Body temperature increased—Ramipril—coronary artery disease	1.63e-05	0.000117	CcSEcCtD
Doxorubicin—Decreased appetite—Lisinopril—coronary artery disease	1.63e-05	0.000117	CcSEcCtD
Doxorubicin—Rash—Perindopril—coronary artery disease	1.62e-05	0.000116	CcSEcCtD
Doxorubicin—Dermatitis—Perindopril—coronary artery disease	1.62e-05	0.000116	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Lisinopril—coronary artery disease	1.62e-05	0.000116	CcSEcCtD
Doxorubicin—Nausea—Telmisartan—coronary artery disease	1.61e-05	0.000116	CcSEcCtD
Doxorubicin—Fatigue—Lisinopril—coronary artery disease	1.61e-05	0.000116	CcSEcCtD
Doxorubicin—Headache—Perindopril—coronary artery disease	1.61e-05	0.000115	CcSEcCtD
Doxorubicin—Urticaria—Timolol—coronary artery disease	1.6e-05	0.000115	CcSEcCtD
Doxorubicin—Pain—Lisinopril—coronary artery disease	1.6e-05	0.000115	CcSEcCtD
Doxorubicin—Constipation—Lisinopril—coronary artery disease	1.6e-05	0.000115	CcSEcCtD
Doxorubicin—Abdominal pain—Timolol—coronary artery disease	1.6e-05	0.000114	CcSEcCtD
Doxorubicin—Body temperature increased—Timolol—coronary artery disease	1.6e-05	0.000114	CcSEcCtD
Doxorubicin—Dizziness—Losartan—coronary artery disease	1.59e-05	0.000114	CcSEcCtD
Doxorubicin—Vomiting—Furosemide—coronary artery disease	1.59e-05	0.000114	CcSEcCtD
Doxorubicin—Rash—Furosemide—coronary artery disease	1.57e-05	0.000113	CcSEcCtD
Doxorubicin—Dermatitis—Furosemide—coronary artery disease	1.57e-05	0.000113	CcSEcCtD
Doxorubicin—Nausea—Captopril—coronary artery disease	1.57e-05	0.000113	CcSEcCtD
Doxorubicin—Headache—Furosemide—coronary artery disease	1.56e-05	0.000112	CcSEcCtD
Doxorubicin—Feeling abnormal—Lisinopril—coronary artery disease	1.54e-05	0.000111	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Lisinopril—coronary artery disease	1.53e-05	0.00011	CcSEcCtD
Doxorubicin—Vomiting—Losartan—coronary artery disease	1.53e-05	0.00011	CcSEcCtD
Doxorubicin—Nausea—Perindopril—coronary artery disease	1.52e-05	0.000109	CcSEcCtD
Doxorubicin—Hypersensitivity—Ramipril—coronary artery disease	1.52e-05	0.000109	CcSEcCtD
Doxorubicin—Rash—Losartan—coronary artery disease	1.52e-05	0.000109	CcSEcCtD
Doxorubicin—Dermatitis—Losartan—coronary artery disease	1.52e-05	0.000109	CcSEcCtD
Doxorubicin—Headache—Losartan—coronary artery disease	1.51e-05	0.000108	CcSEcCtD
Doxorubicin—Urticaria—Lisinopril—coronary artery disease	1.49e-05	0.000107	CcSEcCtD
Doxorubicin—Hypersensitivity—Timolol—coronary artery disease	1.49e-05	0.000107	CcSEcCtD
Doxorubicin—Nausea—Furosemide—coronary artery disease	1.48e-05	0.000106	CcSEcCtD
Doxorubicin—Asthenia—Ramipril—coronary artery disease	1.48e-05	0.000106	CcSEcCtD
Doxorubicin—Body temperature increased—Lisinopril—coronary artery disease	1.48e-05	0.000106	CcSEcCtD
Doxorubicin—Abdominal pain—Lisinopril—coronary artery disease	1.48e-05	0.000106	CcSEcCtD
Doxorubicin—Pruritus—Ramipril—coronary artery disease	1.46e-05	0.000105	CcSEcCtD
Doxorubicin—Asthenia—Timolol—coronary artery disease	1.45e-05	0.000104	CcSEcCtD
Doxorubicin—Nausea—Losartan—coronary artery disease	1.43e-05	0.000102	CcSEcCtD
Doxorubicin—Pruritus—Timolol—coronary artery disease	1.43e-05	0.000102	CcSEcCtD
Doxorubicin—Diarrhoea—Ramipril—coronary artery disease	1.41e-05	0.000101	CcSEcCtD
Doxorubicin—Diarrhoea—Timolol—coronary artery disease	1.38e-05	9.9e-05	CcSEcCtD
Doxorubicin—Hypersensitivity—Lisinopril—coronary artery disease	1.38e-05	9.89e-05	CcSEcCtD
Doxorubicin—Dizziness—Ramipril—coronary artery disease	1.36e-05	9.78e-05	CcSEcCtD
Doxorubicin—Asthenia—Lisinopril—coronary artery disease	1.34e-05	9.63e-05	CcSEcCtD
Doxorubicin—Dizziness—Timolol—coronary artery disease	1.33e-05	9.57e-05	CcSEcCtD
Doxorubicin—Pruritus—Lisinopril—coronary artery disease	1.32e-05	9.49e-05	CcSEcCtD
Doxorubicin—Vomiting—Ramipril—coronary artery disease	1.31e-05	9.41e-05	CcSEcCtD
Doxorubicin—Rash—Ramipril—coronary artery disease	1.3e-05	9.33e-05	CcSEcCtD
Doxorubicin—Dermatitis—Ramipril—coronary artery disease	1.3e-05	9.32e-05	CcSEcCtD
Doxorubicin—Headache—Ramipril—coronary artery disease	1.29e-05	9.27e-05	CcSEcCtD
Doxorubicin—Vomiting—Timolol—coronary artery disease	1.28e-05	9.2e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Lisinopril—coronary artery disease	1.28e-05	9.18e-05	CcSEcCtD
Doxorubicin—Rash—Timolol—coronary artery disease	1.27e-05	9.12e-05	CcSEcCtD
Doxorubicin—Dermatitis—Timolol—coronary artery disease	1.27e-05	9.11e-05	CcSEcCtD
Doxorubicin—Headache—Timolol—coronary artery disease	1.26e-05	9.06e-05	CcSEcCtD
Doxorubicin—Dizziness—Lisinopril—coronary artery disease	1.24e-05	8.87e-05	CcSEcCtD
Doxorubicin—Nausea—Ramipril—coronary artery disease	1.23e-05	8.79e-05	CcSEcCtD
Doxorubicin—Nausea—Timolol—coronary artery disease	1.2e-05	8.59e-05	CcSEcCtD
Doxorubicin—Vomiting—Lisinopril—coronary artery disease	1.19e-05	8.53e-05	CcSEcCtD
Doxorubicin—Rash—Lisinopril—coronary artery disease	1.18e-05	8.46e-05	CcSEcCtD
Doxorubicin—Dermatitis—Lisinopril—coronary artery disease	1.18e-05	8.45e-05	CcSEcCtD
Doxorubicin—Headache—Lisinopril—coronary artery disease	1.17e-05	8.41e-05	CcSEcCtD
Doxorubicin—Nausea—Lisinopril—coronary artery disease	1.11e-05	7.97e-05	CcSEcCtD
Doxorubicin—ABCG2—Metabolism—MTHFR—coronary artery disease	9.95e-07	8.92e-06	CbGpPWpGaD
Doxorubicin—NOS2—Disease—IL6—coronary artery disease	9.92e-07	8.89e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—SERPINE1—coronary artery disease	9.86e-07	8.84e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3C2A—coronary artery disease	9.79e-07	8.78e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—HBA1—coronary artery disease	9.79e-07	8.78e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP2C19—coronary artery disease	9.79e-07	8.78e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—LIPC—coronary artery disease	9.79e-07	8.78e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—DCN—coronary artery disease	9.73e-07	8.72e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—APOC3—coronary artery disease	9.73e-07	8.72e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—LDLR—coronary artery disease	9.67e-07	8.67e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	9.64e-07	8.64e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC27A1—coronary artery disease	9.61e-07	8.61e-06	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTGS2—coronary artery disease	9.6e-07	8.61e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CXCL8—coronary artery disease	9.6e-07	8.6e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTT1—coronary artery disease	9.56e-07	8.56e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SLC9A1—coronary artery disease	9.56e-07	8.56e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—FGF2—coronary artery disease	9.55e-07	8.56e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ALDH2—coronary artery disease	9.47e-07	8.49e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AGT—coronary artery disease	9.46e-07	8.47e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GCLC—coronary artery disease	9.45e-07	8.47e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CETP—coronary artery disease	9.45e-07	8.47e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CPT1B—coronary artery disease	9.42e-07	8.44e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—LCAT—coronary artery disease	9.42e-07	8.44e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NOS3—coronary artery disease	9.42e-07	8.44e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SDC1—coronary artery disease	9.34e-07	8.37e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	9.28e-07	8.31e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—APOE—coronary artery disease	9.26e-07	8.3e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOA4—coronary artery disease	9.25e-07	8.29e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—VEGFA—coronary artery disease	9.23e-07	8.27e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—LIPC—coronary artery disease	9.23e-07	8.27e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	9.23e-07	8.27e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—HBA1—coronary artery disease	9.23e-07	8.27e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP2C19—coronary artery disease	9.23e-07	8.27e-06	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTGS2—coronary artery disease	9.21e-07	8.25e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CASP3—coronary artery disease	9.19e-07	8.23e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PPARG—coronary artery disease	9.17e-07	8.22e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—APOC3—coronary artery disease	9.17e-07	8.22e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—APOA1—coronary artery disease	9.16e-07	8.21e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—JAK2—coronary artery disease	9.15e-07	8.2e-06	CbGpPWpGaD
Doxorubicin—NOS2—Disease—AKT1—coronary artery disease	9.15e-07	8.2e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—IL6—coronary artery disease	9.11e-07	8.17e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—LDLR—coronary artery disease	9.11e-07	8.17e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—POMC—coronary artery disease	9.04e-07	8.11e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTT1—coronary artery disease	9.01e-07	8.07e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SLC9A1—coronary artery disease	9.01e-07	8.07e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GSTP1—coronary artery disease	8.98e-07	8.05e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCND1—coronary artery disease	8.94e-07	8.02e-06	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PIK3CA—coronary artery disease	8.93e-07	8.01e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PDHA1—coronary artery disease	8.93e-07	8e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GCLM—coronary artery disease	8.93e-07	8e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GCLC—coronary artery disease	8.9e-07	7.98e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CETP—coronary artery disease	8.9e-07	7.98e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PPARGC1A—coronary artery disease	8.9e-07	7.97e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PPARG—coronary artery disease	8.87e-07	7.95e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—HMOX1—coronary artery disease	8.86e-07	7.94e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PSMA6—coronary artery disease	8.82e-07	7.91e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PSMB5—coronary artery disease	8.82e-07	7.91e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SDC1—coronary artery disease	8.8e-07	7.89e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—POMC—coronary artery disease	8.75e-07	7.84e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CAT—coronary artery disease	8.74e-07	7.83e-06	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PIK3CA—coronary artery disease	8.7e-07	7.79e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MMP9—coronary artery disease	8.68e-07	7.78e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP11B2—coronary artery disease	8.65e-07	7.75e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—TXNRD1—coronary artery disease	8.65e-07	7.75e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CTGF—coronary artery disease	8.62e-07	7.73e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PIK3CA—coronary artery disease	8.62e-07	7.73e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTGS2—coronary artery disease	8.61e-07	7.72e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—HMGCR—coronary artery disease	8.54e-07	7.66e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GOT2—coronary artery disease	8.54e-07	7.66e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC22A3—coronary artery disease	8.52e-07	7.64e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—APOB—coronary artery disease	8.48e-07	7.6e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TGFB1—coronary artery disease	8.47e-07	7.59e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—AKT1—coronary artery disease	8.41e-07	7.54e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ARNTL—coronary artery disease	8.4e-07	7.53e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HADH—coronary artery disease	8.4e-07	7.53e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	8.38e-07	7.51e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PSMB5—coronary artery disease	8.32e-07	7.45e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PSMA6—coronary artery disease	8.32e-07	7.45e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MAPK1—coronary artery disease	8.31e-07	7.44e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GSTM1—coronary artery disease	8.25e-07	7.4e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ALB—coronary artery disease	8.25e-07	7.39e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CTGF—coronary artery disease	8.12e-07	7.28e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—LPL—coronary artery disease	8.1e-07	7.26e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PPARG—coronary artery disease	8.07e-07	7.23e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—HMGCR—coronary artery disease	8.05e-07	7.21e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GOT2—coronary artery disease	8.05e-07	7.21e-06	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PIK3CA—coronary artery disease	8.01e-07	7.18e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ALB—coronary artery disease	7.98e-07	7.15e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GPX2—coronary artery disease	7.96e-07	7.13e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOA2—coronary artery disease	7.96e-07	7.13e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	7.96e-07	7.13e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—POMC—coronary artery disease	7.96e-07	7.13e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GPX1—coronary artery disease	7.9e-07	7.08e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—NOS3—coronary artery disease	7.89e-07	7.07e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HK1—coronary artery disease	7.86e-07	7.05e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GPX4—coronary artery disease	7.86e-07	7.05e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SULT1A1—coronary artery disease	7.86e-07	7.05e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCG5—coronary artery disease	7.86e-07	7.05e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PLCB1—coronary artery disease	7.86e-07	7.04e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—VEGFA—coronary artery disease	7.8e-07	6.99e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HADHA—coronary artery disease	7.77e-07	6.96e-06	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IL6—coronary artery disease	7.7e-07	6.9e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CD36—coronary artery disease	7.7e-07	6.9e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTA1—coronary artery disease	7.68e-07	6.88e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—NOS3—coronary artery disease	7.63e-07	6.84e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ABCA1—coronary artery disease	7.62e-07	6.82e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PPP2CA—coronary artery disease	7.6e-07	6.81e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—LPA—coronary artery disease	7.59e-07	6.81e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PLCB1—coronary artery disease	7.4e-07	6.63e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GGT1—coronary artery disease	7.38e-07	6.61e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GOT1—coronary artery disease	7.38e-07	6.61e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PLCB3—coronary artery disease	7.35e-07	6.59e-06	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—AKT1—coronary artery disease	7.3e-07	6.54e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—MTHFR—coronary artery disease	7.29e-07	6.54e-06	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PIK3CA—coronary artery disease	7.28e-07	6.53e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOA5—coronary artery disease	7.28e-07	6.52e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ALB—coronary artery disease	7.26e-07	6.5e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTGS2—coronary artery disease	7.21e-07	6.46e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PIK3CA—coronary artery disease	7.21e-07	6.46e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ABCA1—coronary artery disease	7.18e-07	6.43e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TGFB1—coronary artery disease	7.16e-07	6.41e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—P4HB—coronary artery disease	7.14e-07	6.4e-06	CbGpPWpGaD
Doxorubicin—NOS3—Disease—AKT1—coronary artery disease	7.1e-07	6.37e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—AKT1—coronary artery disease	7.04e-07	6.31e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MAPK1—coronary artery disease	7.02e-07	6.29e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	7.01e-07	6.28e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTGS2—coronary artery disease	6.98e-07	6.25e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GOT1—coronary artery disease	6.95e-07	6.23e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GGT1—coronary artery disease	6.95e-07	6.23e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—NOS3—coronary artery disease	6.94e-07	6.22e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AGT—coronary artery disease	6.93e-07	6.21e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—APOE—coronary artery disease	6.79e-07	6.09e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—APOA1—coronary artery disease	6.71e-07	6.02e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTP1—coronary artery disease	6.62e-07	5.94e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—VCAN—coronary artery disease	6.61e-07	5.92e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PPARGC1A—coronary artery disease	6.56e-07	5.88e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALDOA—coronary artery disease	6.56e-07	5.87e-06	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—AKT1—coronary artery disease	6.55e-07	5.87e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—HMOX1—coronary artery disease	6.53e-07	5.85e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CAT—coronary artery disease	6.45e-07	5.78e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL6—coronary artery disease	6.38e-07	5.72e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—DCN—coronary artery disease	6.36e-07	5.7e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTGS2—coronary artery disease	6.35e-07	5.69e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—APOB—coronary artery disease	6.26e-07	5.61e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTP1—coronary artery disease	6.24e-07	5.59e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TGFB1—coronary artery disease	6.23e-07	5.58e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALDH2—coronary artery disease	6.19e-07	5.55e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	6.18e-07	5.54e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—HMOX1—coronary artery disease	6.16e-07	5.52e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MAPK1—coronary artery disease	6.11e-07	5.47e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PIK3CA—coronary artery disease	6.09e-07	5.46e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTM1—coronary artery disease	6.09e-07	5.46e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CAT—coronary artery disease	6.07e-07	5.44e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP2C19—coronary artery disease	6.03e-07	5.41e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—LIPC—coronary artery disease	6.03e-07	5.41e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	6.03e-07	5.41e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HBA1—coronary artery disease	6.03e-07	5.41e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOC3—coronary artery disease	6e-07	5.37e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—LPL—coronary artery disease	5.98e-07	5.35e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—LDLR—coronary artery disease	5.96e-07	5.34e-06	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—AKT1—coronary artery disease	5.95e-07	5.33e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PPARG—coronary artery disease	5.92e-07	5.3e-06	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PIK3CA—coronary artery disease	5.91e-07	5.29e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—APOB—coronary artery disease	5.9e-07	5.28e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTT1—coronary artery disease	5.89e-07	5.28e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC9A1—coronary artery disease	5.89e-07	5.28e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AKT1—coronary artery disease	5.89e-07	5.28e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—POMC—coronary artery disease	5.83e-07	5.23e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GPX1—coronary artery disease	5.83e-07	5.22e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GCLC—coronary artery disease	5.82e-07	5.22e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CETP—coronary artery disease	5.82e-07	5.22e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SDC1—coronary artery disease	5.76e-07	5.16e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTM1—coronary artery disease	5.74e-07	5.14e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CD36—coronary artery disease	5.68e-07	5.09e-06	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PIK3CA—coronary artery disease	5.66e-07	5.08e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—LPL—coronary artery disease	5.63e-07	5.05e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PPP2CA—coronary artery disease	5.61e-07	5.02e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GPX1—coronary artery disease	5.49e-07	4.92e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PSMA6—coronary artery disease	5.44e-07	4.87e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PSMB5—coronary artery disease	5.44e-07	4.87e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL6—coronary artery disease	5.39e-07	4.83e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MTHFR—coronary artery disease	5.38e-07	4.82e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CD36—coronary artery disease	5.35e-07	4.79e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ALB—coronary artery disease	5.32e-07	4.77e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CTGF—coronary artery disease	5.31e-07	4.76e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PIK3CA—coronary artery disease	5.3e-07	4.75e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PPP2CA—coronary artery disease	5.28e-07	4.73e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GOT2—coronary artery disease	5.26e-07	4.72e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HMGCR—coronary artery disease	5.26e-07	4.72e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AGT—coronary artery disease	5.11e-07	4.58e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—NOS3—coronary artery disease	5.09e-07	4.56e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MTHFR—coronary artery disease	5.07e-07	4.54e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—APOE—coronary artery disease	5.01e-07	4.49e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AKT1—coronary artery disease	4.98e-07	4.46e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—APOA1—coronary artery disease	4.95e-07	4.44e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PLCB1—coronary artery disease	4.84e-07	4.34e-06	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—AKT1—coronary artery disease	4.83e-07	4.33e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AGT—coronary artery disease	4.82e-07	4.32e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—APOE—coronary artery disease	4.72e-07	4.23e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IL6—coronary artery disease	4.69e-07	4.21e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCA1—coronary artery disease	4.69e-07	4.2e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—APOA1—coronary artery disease	4.67e-07	4.18e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS2—coronary artery disease	4.65e-07	4.17e-06	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—AKT1—coronary artery disease	4.63e-07	4.15e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GGT1—coronary artery disease	4.54e-07	4.07e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GOT1—coronary artery disease	4.54e-07	4.07e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3CA—coronary artery disease	4.44e-07	3.98e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PPARG—coronary artery disease	4.36e-07	3.91e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—AKT1—coronary artery disease	4.33e-07	3.88e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—POMC—coronary artery disease	4.3e-07	3.86e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3CA—coronary artery disease	4.29e-07	3.85e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PPARG—coronary artery disease	4.11e-07	3.68e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTP1—coronary artery disease	4.08e-07	3.66e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—POMC—coronary artery disease	4.05e-07	3.63e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	4.04e-07	3.62e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HMOX1—coronary artery disease	4.03e-07	3.61e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CAT—coronary artery disease	3.97e-07	3.56e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ALB—coronary artery disease	3.92e-07	3.52e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3CA—coronary artery disease	3.91e-07	3.5e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOB—coronary artery disease	3.86e-07	3.46e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NOS3—coronary artery disease	3.75e-07	3.36e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTM1—coronary artery disease	3.75e-07	3.36e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ALB—coronary artery disease	3.7e-07	3.31e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—LPL—coronary artery disease	3.68e-07	3.3e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—AKT1—coronary artery disease	3.63e-07	3.25e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GPX1—coronary artery disease	3.59e-07	3.22e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NOS3—coronary artery disease	3.54e-07	3.17e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—AKT1—coronary artery disease	3.51e-07	3.14e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CD36—coronary artery disease	3.5e-07	3.13e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPP2CA—coronary artery disease	3.45e-07	3.1e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS2—coronary artery disease	3.43e-07	3.08e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MTHFR—coronary artery disease	3.31e-07	2.97e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS2—coronary artery disease	3.23e-07	2.9e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AKT1—coronary artery disease	3.19e-07	2.86e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AGT—coronary artery disease	3.15e-07	2.82e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOE—coronary artery disease	3.09e-07	2.77e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOA1—coronary artery disease	3.05e-07	2.73e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3CA—coronary artery disease	2.86e-07	2.57e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPARG—coronary artery disease	2.69e-07	2.41e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—POMC—coronary artery disease	2.65e-07	2.38e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALB—coronary artery disease	2.42e-07	2.17e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AKT1—coronary artery disease	2.34e-07	2.1e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NOS3—coronary artery disease	2.31e-07	2.07e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS2—coronary artery disease	2.11e-07	1.89e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3CA—coronary artery disease	2.11e-07	1.89e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.99e-07	1.78e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AKT1—coronary artery disease	1.72e-07	1.55e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AKT1—coronary artery disease	1.63e-07	1.46e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.3e-07	1.17e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AKT1—coronary artery disease	1.06e-07	9.52e-07	CbGpPWpGaD
